Company news

Samsung Biologics Co., Ltd. news in 2026

Samsung Biologics Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

PolyPeptide Group: Definitive end result of the public tender offer of Samsung Biologics Co., Ltd.

November 5, 2026

PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd.

October 13, 2026

Samsung Biologics publishes prospectus for PolyPeptide public tender offer

August 31, 2026

Samsung Biologics Reports Second Quarter 2026 Financial Results

July 22, 2026

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

July 19, 2026

Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth

June 30, 2026

2025 FY Audited Financial Statements (Consolidated)

May 20, 2026

Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline

May 6, 2026

Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year

May 5, 2026

Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific

April 29, 2026

Samsung Biologics Reports First Quarter 2026 Financial Results

April 22, 2026

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

March 31, 2026

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

March 26, 2026

Samsung Biologics Announces Collaboration with Lilly to Establish New Gateway Labs Site in Korea

March 10, 2026

Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

February 6, 2026

CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access

February 3, 2026

Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating

January 28, 2026

Samsung Biologics reports fourth quarter and fiscal year 2025 financial results

January 19, 2026